Literature DB >> 21327038

The interaction of gut microbes with host ABC transporters.

Regino Mercado-Lubo1, Beth A McCormick.   

Abstract

ATP binding cassette (ABC) transporters are increasingly recognized for their ability to modulate the absorption, distribution, metabolism, secretion and toxicity of xenobiotics. In addition to their essential function in drug resistance, there is also emerging evidence documenting the important role ABC transporters play in tissue defense. In this respect, the gastrointestinal tract represents a critical vanguard of defense against oral exposure of drugs while at the same time functions as a physical barrier between the lumenal contents (including bacteria) and the intestinal epithelium. Given emerging evidence suggesting that multidrug resistance protein (MDR) plays an important role in host-bacterial interactions in the gastrointestinal tract, this review will discuss the interplay between MDR of the intestinal epithelial cell barrier and gut microbes in health and disease. In particular, we will explore host-microbe interactions involving three apically restricted ABC transporters of the intestinal epithelium; P-glycoprotein (P-gp), multidrug resistance-associated protein 2 (MRP2) and cystic fibrosis transmembrane regulator (CFTR).

Entities:  

Year:  2010        PMID: 21327038      PMCID: PMC3023614          DOI: 10.4161/gmic.1.5.12925

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  56 in total

1.  Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.

Authors:  Tonghui Ma; Jay R Thiagarajah; Hong Yang; Nitin D Sonawane; Chiara Folli; Luis J V Galietta; A S Verkman
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 2.  The human ATP-binding cassette (ABC) transporter superfamily.

Authors:  M Dean; Y Hamon; G Chimini
Journal:  J Lipid Res       Date:  2001-07       Impact factor: 5.922

3.  Multidrug resistance protein mrp2 mediates ATP-dependent transport of classic renal organic anion p-aminohippurate.

Authors:  R A Van Aubel; J G Peters; R Masereeuw; C H Van Os; F G Russel
Journal:  Am J Physiol Renal Physiol       Date:  2000-10

4.  Epidemic listeriosis--evidence for transmission by food.

Authors:  W F Schlech; P M Lavigne; R A Bortolussi; A C Allen; E V Haldane; A J Wort; A W Hightower; S E Johnson; S H King; E S Nicholls; C V Broome
Journal:  N Engl J Med       Date:  1983-01-27       Impact factor: 91.245

5.  Differences in P-glycoprotein-170 expression and activity between Crohn's disease and ulcerative colitis.

Authors:  B Yacyshyn; W Maksymowych; M B Bowen-Yacyshyn
Journal:  Hum Immunol       Date:  1999-08       Impact factor: 2.850

6.  Increased pulmonary and intestinal permeability in Crohn's disease.

Authors:  A Adenis; J F Colombel; P Lecouffe; B Wallaert; B Hecquet; X Marchandise; A Cortot
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

Review 7.  Mechanisms of active intestinal inflammation and potential down-regulation via lipoxins.

Authors:  Andrew T Gewirtz; Andrew S Neish; James L Madara
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

8.  Multidrug resistance 1 gene polymorphism and susceptibility to inflammatory bowel disease.

Authors:  S Ardizzone; G Maconi; V Bianchi; A Russo; E Colombo; A Cassinotti; C Penati; M L Tenchini; G Bianchi Porro
Journal:  Inflamm Bowel Dis       Date:  2007-05       Impact factor: 5.325

9.  Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels.

Authors:  Hans Blokzijl; Sara Vander Borght; Lisette I H Bok; Louis Libbrecht; Mariska Geuken; Fiona A J van den Heuvel; Gerard Dijkstra; Tania A D Roskams; Han Moshage; Peter L M Jansen; Klaas Nico Faber
Journal:  Inflamm Bowel Dis       Date:  2007-06       Impact factor: 5.325

10.  Commensal bacteria increase invasion of intestinal epithelium by Salmonella enterica serovar Typhi.

Authors:  Jeffrey B Lyczak
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

View more
  7 in total

1.  The human P-glycoprotein transporter enhances the type I interferon response to Listeria monocytogenes infection.

Authors:  Nadejda Sigal; Millie Kaplan Zeevi; Shiri Weinstein; Dan Peer; Anat A Herskovits
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

2.  CRISPR/Cas9 mutagenesis reveals a role for ABCB1 in gut immune responses to Vibrio diazotrophicus in sea urchin larvae.

Authors:  Travis J Fleming; Catherine S Schrankel; Himanshu Vyas; Hannah D Rosenblatt; Amro Hamdoun
Journal:  J Exp Biol       Date:  2021-04-15       Impact factor: 3.312

3.  High ABCC2 and low ABCG2 gene expression are early events in the colorectal adenoma-carcinoma sequence.

Authors:  Vibeke Andersen; Lotte K Vogel; Tine Iskov Kopp; Mona Sæbø; Annika W Nonboe; Julian Hamfjord; Elin H Kure; Ulla Vogel
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

4.  P-glycoprotein multidrug transporter in inflammatory bowel diseases: More questions than answers.

Authors:  Elke Cario
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

5.  Whole-genome microarray analysis and functional characterization reveal distinct gene expression profiles and patterns in two mouse models of ileal inflammation.

Authors:  Leela Rani Avula; Dries Knapen; Roeland Buckinx; Lucia Vergauwen; Dirk Adriaensen; Luc Van Nassauw; Jean-Pierre Timmermans
Journal:  BMC Genomics       Date:  2012-08-06       Impact factor: 3.969

Review 6.  The power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancer.

Authors:  Sheetal Parida; Dipali Sharma
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-04-11       Impact factor: 10.680

Review 7.  Pharmacological Efficacy/Toxicity of Drugs: A Comprehensive Update About the Dynamic Interplay of Microbes.

Authors:  Juan Antonio Gimenez-Bastida; Lucia Martinez Carreras; Angela Moya-Pérez; José Moisés Laparra Llopis
Journal:  J Pharm Sci       Date:  2017-10-26       Impact factor: 3.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.